Penumbra, Inc. (PEN) Stock

Penumbra, Inc. is a global leader in the design, development, manufacturing, and distribution of innovative medical devices, serving healthcare professionals and patients worldwide. The company specializes in a comprehensive range of advanced technologies aimed at neurovascular and vascular disorders. Its flagship products include aspiration-based thrombectomy systems and associated devices like the Penumbra System, known for its efficacy in mechanical thrombectomy procedures. These systems operate under various brands such as Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE, ensuring robust solutions for diverse clinical needs.

In the neurovascular domain, Penumbra offers cutting-edge embolization coiling systems such as Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil, addressing a spectrum of aneurysms and other neurovascular lesions. Additionally, the company provides neurovascular access systems like Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM, facilitating critical intracranial access essential for various neurovascular therapies.

Beyond neurovascular solutions, Penumbra is also recognized for its neurosurgical aspiration tools under the Artemis Neuro Evacuation Device brand and aspiration-based thrombectomy systems like the Indigo System for vascular applications. The company's commitment extends to peripheral embolization with detachable embolic coil systems such as Ruby Coil and Ruby LP, and microcatheters like LANTERN for precise delivery of occlusion devices.

Headquartered in Alameda, California, Penumbra was established in 2004 and has established a strong global presence through direct sales channels and partnerships with distributors. By continuously advancing its portfolio of medical innovations, Penumbra remains dedicated to enhancing patient outcomes and revolutionizing treatment standards in neurovascular and vascular healthcare.